140 mg, medicinal patch
(diclofenac sodium)
important information for the patient.
This medicine should always be used exactly as described in the patient information leaflet or as advised by your doctor or pharmacist.
Olfen Patch is a pain-relieving medicine. It belongs to a group of non-steroidal anti-inflammatory drugs (NSAIDs).
Olfen Patch is used locally for short-term treatment to relieve pain associated with
sudden strains, sprains, or bruises in the arms and legs caused by blunt injuries.
Side effects can be reduced by using the lowest possible dose for the shortest duration.
Important warnings:
The patch should only be applied to undamaged skin. It should not be worn during bathing.
After removing the medicinal patch, avoid exposing the treated area to direct sunlight and sunlamps for about one day after removing the Olfen Patch to minimize the risk of photosensitivity.
Do not use diclofenac-containing medicines or other NSAIDs at the same time, either locally or systemically.
Tell your doctor or pharmacist about all medicines you are taking now or recently, and about medicines you plan to use. If Olfen Patch is used correctly, only a small amount of diclofenac penetrates the body, so interactions that may occur with oral administration of the medicine are unlikely.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Pregnancy
In the first six months of pregnancy, Olfen Patch should only be used after consulting a doctor.
During the last three months of pregnancy, do not use Olfen Patch due to the increased risk of complications for the mother and child (see "When not to use Olfen Patch").
Fertility
Olfen Patch should not be used in women who are planning to become pregnant or have difficulty becoming pregnant, or are undergoing investigations to determine the cause of infertility.
Breastfeeding
Before using any medicine, consult your doctor or pharmacist.
Only small amounts of diclofenac pass into breast milk. For short-term use of Olfen Patch, it is not necessary to stop breastfeeding, as no adverse effects have been observed in the infant.
However, Olfen Patch should not be applied near the breast.
Olfen Patch has no or negligible influence on the ability to drive and use machines.
Olfen Patch contains propylene glycol and butylhydroxytoluene.
The medicine contains 1400 mg of propylene glycol in each patch. Propylene glycol may cause skin irritation.
Butylhydroxytoluene may cause a local skin reaction (e.g., contact dermatitis) or eye and mucous membrane irritation.
This medicine should always be used exactly as advised by your doctor. If you are unsure, consult your doctor or pharmacist.
Apply one medicinal patch to the painful area twice a day, in the morning and evening. Do not use more than two medicinal patches per day, even if injuries occur in several places. Use only on one painful area at a time.
Olfen Patch should only be applied to undamaged, non-diseased skin.
Elderly patients should use Olfen Patch with caution, as they are more likely to experience side effects.
In patients with kidney, heart, or liver problems, Olfen Patch should be used with caution.
There is a lack of sufficient data on the efficacy and safety of use in children and adolescents under 16 years of age.
For cutaneous use only. Do not swallow!
If necessary, a knitted bandage can be used to secure the patch in the desired position.
Do not use the medicinal patch under a non-permeable (occlusive) dressing.
Do not divide the patches into parts.
Used patches should be folded in half, with the adhesive side inward.
Due to limited data, only short-term therapy is recommended.
Olfen Patch should not be used for more than 3 days without consulting a doctor.
The therapeutic benefits of using the patch for more than 7 days have not been confirmed.
In the case of adolescents aged 16 and over and adults, if it is necessary to use the product for more than 7 days to relieve pain or if symptoms worsen, parents or patients should consult a doctor.
In case of severe side effects due to accidental overdose (e.g., by children) or incorrect use of Olfen Patch, consult a doctor. Based on the assessment of the degree of poisoning, the doctor will decide what corrective actions to take.
Do not use a double dose to make up for a missed dose.
If you have any further doubts about the use of this medicine, consult your doctor or pharmacist.
Like all medicines, Olfen Patch can cause side effects, although not everybody gets them.
sudden itchy rash (hives), swelling of hands, feet, ankles, face, lips, mouth, or throat, difficulty breathing, sudden drop in blood pressure, or feeling of weakness.
Common(may affect up to 1 in 10 people)
Reactions at the application site, rash, eruption, redness, skin inflammation (including allergic and contact dermatitis), skin swelling, itching, burning sensation.
Uncommon(may affect up to 1 in 100 people)
Generalized skin rash, allergic reactions (including hives), skin and mucous membrane swelling, anaphylactic reactions, photosensitivity.
Rare(may affect up to 1 in 1,000 people)
Blistering skin, dry skin
Very rare(may affect up to 1 in 10,000 people)
Asthma attack, severe skin eruption, pustular rash, rash with ulcers
Frequency not known(frequency cannot be estimated from the available data) Hematoma at the application site
The absorption of diclofenac after topical application is very low, resulting in very low plasma concentrations compared to oral administration. The likelihood of systemic side effects (such as gastrointestinal disorders, liver or kidney function disorders, bronchospasm) is therefore negligible compared to the likelihood of side effects after oral administration of diclofenac. However, if diclofenac is used for too long on large areas of skin, systemic side effects may occur.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocides
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use Olfen Patch after the expiry date stated on the carton after the words "Expiry date" or "EXP".
The expiry date refers to the last day of that month. The batch number on the packaging is after the abbreviation "Lot".
Do not store above 25°C.
Store in the original packaging to protect from light and drying.
Store the sachet tightly closed to protect from drying.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is: diclofenac sodium. Each medicinal patch contains 140 mg of diclofenac sodium.
The other ingredients are: macrogol lauryl ether (9EO), diisopropyl adipate, glycerol, propylene glycol, liquid crystallizing sorbitol (E 420), sodium polyacrylate, sodium carmellose, butyl methacrylate copolymer, anhydrous colloidal silica, light natural kaolin, sodium metabisulfite (E 221), disodium edetate, butylhydroxytoluene (E 321), aluminum potassium sulfate, tartaric acid, levomenthol, purified water, polyester backing layer (EL-8100S), protective polypropylene film.
Olfen Patch is a medicinal patch with a size of 10 cm x 14 cm with a uniform adhesive layer applied to the dressing, white to light brown in color; protected by a protective layer.
Olfen Patch is available in packs containing 2 medicinal patches in one sachet, 5 medicinal patches in 1 sachet, or 10 medicinal patches in 2 sachets of 5 patches each with the possibility of reclosing.
Not all pack sizes may be marketed.
Marketing authorization holder
Teva B.V.
Swensweg 5
2031 GA Haarlem
Netherlands
Manufacturer
Merckle GmbH
Ludwig-Merckle-Strasse 3
89143 Blaubeuren
Germany
Manufacturers/Importers
Sofarimex-Industria Química e Farmacêutica, SA
Av. Das Industrias
Alto De Colaride/ Algualva
2735-213 Cacem
Portugal
Haleon France
100 route de Versailles
78164 Marly-Le-Roi-Cedex
France
Teva Operations Poland Sp. z o.o
ul. Mogilska 80,
31-546 Kraków
France:
VoltarenPlast 1%
Germany:
Olfen Patch
Poland:
Olfen Patch
Portugal:
Olfen
Date of revision of the leaflet:August 2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.